biosimilar semaglutide Christian Schmollinger: China's first Ozempic drug applies for approval, ETHealthworld Sandoz to launch biosimilar semaglutide

Tesamorelin has a more established evidence base, primarily in the context of HIV-associated lipodystrophy, where pivotal randomised controlled trials (including Falutz et al., NEJM, 2010) demonstrated statistically significant reductions in visceral adipose tissue

Novo Nordisk, GoodRx selling Ozempic at half cost for customers paying cash Novo Nordisk and GoodRx announced a partnership this week to sell products Ozempic and Wegovy at half their normal cost to patients who pay for the medications with cash

Removes and fades dark spots, acne scars, sun spots, and blemishes

Medical history, medication interactions, lifestyle readiness, and individual metabolic factors all inform whether GLP-1 therapy aligns with your health goals and clinical needs